2021 National Survey on Prior Authorization Burden and Its Impact on Gastroenterology Practice.

Authors:
Shah ED; Amann ST; Hobley J; Islam S; Taunk R and 1 more

Journal:
Am J Gastroenterol

Publication Year: 2022

DOI:
10.14309/ajg.0000000000001728

PMCID:
PMC9060934

PMID:
35296630

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Am J Gastroenterol

Abbreviation: Am J Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Review of the Cardiovascular Safety of Prucalopride in Patients With Chronic Idiopathic Constipat…
Tack J; Derakhchan K; Gabriel A and 6 more (2023) - Transparency Score: 3/6
Crohn's Disease-Associated Anorectal Cancer Has a Poor Prognosis With High Local Recurrence: A Suba…
Ogino T; Mizushima T; Fujii M and 42 more (2023) - Transparency Score: 3/6
Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients With…
Corazziari ES; Gasbarrini A; D'Alba L and 17 more (2023) - Transparency Score: 4/6
Poor Subjective Sleep Quality Predicts Symptoms in Irritable Bowel Syndrome Using the Experience Sa…
Topan R; Vork L; Fitzke H and 7 more (2023) - Transparency Score: 3/6
Prognostic Value of the Modified Rutgeerts Score for Long-Term Outcomes After Primary Ileocecal Res…
Bak MTJ; Bak MTJ; Ten Bokkel Huinink S and 13 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST Guarantor of the article: Eric D. Shah, MD, MBA, FACG. Specific author contributions: All authors were involved in study concept and design and interpretation of data. E.D.S.: authored the initial draft of the article and performed statistical analysis. All authors critically revised the article and approved the final copy. Financial support: None to report. Potential competing interests: E.D.S.: consulted for Bausch Health and GI Supply. S.T.A.: consulted for Eli Lilly."

Evidence found in paper:

"Financial support: None to report."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025